FDA's Tobacco Center To Mull First Modified-Risk Claim Application
This article was originally published in The Tan Sheet
Executive Summary
FDA will have a complex public health impact equation to balance as its Center for Tobacco Products faces its first application for "modified-risk" tobacco product claims
You may also be interested in...
Between A Rock Creek And A Hard Place: Firm Stops Supplement Sales, Weathers Litigation
Rock Creek Pharmaceuticals faces investor and consumer class-action complaints on top of ending sales of its nutritionals following an FDA warning. Moreover, the company name is known more in connection with federal officials’ investigation of the former governor of Virginia than for its products.
Between A Rock Creek And A Hard Place: Firm Stops Supplement Sales, Weathers Litigation
Rock Creek Pharmaceuticals faces investor and consumer class-action complaints on top of ending sales of its nutritionals following an FDA warning. Moreover, the company name is known more in connection with federal officials’ investigation of the former governor of Virginia than for its products.
Star Scientific IND Blocks Supplement Marketing Options – FDA
An FDA warning letter deems Star Scientific’s CigRx and Anatabloc supplements unapproved drugs due to multiple issues, including claims. The firm’s approved IND study for the ingredient also prevents its use in supplements, the agency says.